I agree that this site is using cookies. You can find further informations here.
X
Balu‐Iyer, Sathy V.
98  results:
Search for persons X
?
1

Preclinical evaluation of cancer immune therapy using patie..:

Shenoy, Gautam N ; Greene, Christopher J ; Bhatta, Maulasri...
Clinical & Translational Immunology.  10 (2021)  2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
2

Tolerogenic form of Factor VIII to prevent inhibitor develo..:

Nguyen, Nhan H. ; Dingman, Robert K. ; Balu‐Iyer, Sathy V.
Journal of Thrombosis and Haemostasis.  19 (2021)  11 - p. 2744-2750 , 2021
Link: https://doi.org/10.1111/..
 
?
3

Effect of an Active Phosphatidylserine Species on Antigen‐S..:

Yau, Fiona C ; Balu‐Iyer, Sathy V
The FASEB Journal.  31 (2017)  S1 - p. , 2017
Link: https://doi.org/10.1096/..
 
?
4

Factor VIII associated with lipidic nanoparticles retains e..:

Shetty, Krithika A. ; Kosloski, Matthew P. ; Mager, Donald E..
Biopharmaceutics & Drug Disposition.  37 (2016)  7 - p. 409-420 , 2016
Link: https://doi.org/10.1002/..
 
?
5

Effects of hypertonic buffer composition on lymph node upta..:

Fathallah, Anas M. ; Turner, Michael R. ; Mager, Donald E..
Biopharmaceutics & Drug Disposition.  36 (2014)  2 - p. 115-125 , 2014
Link: https://doi.org/10.1002/..
 
?
6

O‐Phospho‐ l ‐Serine mediates Hyporesponsiveness toward FVI..:

Fathallah, Anas M. ; Ramakrishnan, Radha ; Balu‐Iyer, Sathy V.
Journal of Pharmaceutical Sciences.  103 (2014)  11 - p. 3457-3463 , 2014
Link: https://doi.org/10.1002/..
 
?
7

Nonlinear pharmacokinetics of factor VIII and its phosphati..:

Kosloski, Matthew P. ; Pisal, Dipak S. ; Mager, Donald E..
Biopharmaceutics & Drug Disposition.  35 (2014)  3 - p. 154-163 , 2014
Link: https://doi.org/10.1002/..
 
?
8

Use of a folding model and in situ spectroscopic techniques..:

Rao, Gauri ; Iyer, Vandana ; Kosloski, Matthew P....
Journal of Pharmaceutical Sciences.  99 (2010)  4 - p. 1697-1706 , 2010
Link: https://doi.org/10.1002/..
 
?
9

A mechanistic marker-based screening tool to predict clinic..:

Jarvi, Nicole L. ; Balu-Iyer, Sathy V.
Communications Medicine.  3 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
10

Phosphatidylserine-mediated oral tolerance:

Nguyen, Nhan H. ; Chak, Vincent ; Keller, Katherine..
Cellular Immunology.  384 (2023)  - p. 104660 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Immunogenicity of Therapeutic Biological Modalities - Lesso..:

Nguyen, Nhan H. ; Jarvi, Nicole L. ; Balu-Iyer, Sathy V.
Journal of Pharmaceutical Sciences.  112 (2023)  9 - p. 2347-2370 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Biophysical Characterization of Tolerogenic Lipid-Based Nan..:

Nguyen, Nhan H. ; Chen, Manlin ; Chak, Vincent.
Journal of Pharmaceutical Sciences.  111 (2022)  7 - p. 2072-2082 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Novel phosphatidylserine-binding molecule enhances antitumo..:

Bhatta, Maulasri ; Shenoy, Gautam N ; Loyall, Jenni L...
Journal for ImmunoTherapy of Cancer.  9 (2021)  10 - p. e003148 , 2021
Link: https://doi.org/10.1136/..
 
?
14

Immunogenicity Challenges Associated with Subcutaneous Deli..:

Jarvi, Nicole L. ; Balu-Iyer, Sathy V.
BioDrugs.  35 (2021)  2 - p. 125-146 , 2021
Link: https://doi.org/10.1007/..
 
?
15

Rational design of a nanoparticle platform for oral prophyl..:

Nguyen, Nhan H. ; Glassman, Fiona Y. ; Dingman, Robert K....
Scientific Reports.  11 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
1-15